These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 11449372
1. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. Choi Y, Woo KM, Ko SH, Lee YJ, Park SJ, Kim HM, Kwon BS. Eur J Immunol; 2001 Jul; 31(7):2179-88. PubMed ID: 11449372 [Abstract] [Full Text] [Related]
2. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T. J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996 [Abstract] [Full Text] [Related]
3. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato T, Mano H, Kumegawa M, Hakeda Y. J Immunol; 2000 Oct 15; 165(8):4254-63. PubMed ID: 11035059 [Abstract] [Full Text] [Related]
4. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF. J Bone Miner Res; 2002 Jul 15; 17(7):1200-10. PubMed ID: 12096833 [Abstract] [Full Text] [Related]
5. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H. J Bone Miner Res; 2001 Nov 15; 16(11):2074-81. PubMed ID: 11697804 [Abstract] [Full Text] [Related]
7. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage. Khapli SM, Mangashetti LS, Yogesha SD, Wani MR. J Immunol; 2003 Jul 01; 171(1):142-51. PubMed ID: 12816992 [Abstract] [Full Text] [Related]
8. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H. J Immunol; 2003 Nov 15; 171(10):5130-9. PubMed ID: 14607912 [Abstract] [Full Text] [Related]
13. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. Tsurukai T, Udagawa N, Matsuzaki K, Takahashi N, Suda T. J Bone Miner Metab; 2000 Nov 15; 18(4):177-84. PubMed ID: 10874596 [Abstract] [Full Text] [Related]
14. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. J Bone Miner Res; 2000 Aug 15; 15(8):1459-66. PubMed ID: 10934644 [Abstract] [Full Text] [Related]